Copyright Reports & Markets. All rights reserved.

Global Brain Tumor Diagnosis And Therapeutics Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Brain Tumor Diagnosis And Therapeutics Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Brain Tumor Diagnosis And Therapeutics Market Size Growth Rate by Product
      • 1.4.2 MRI
      • 1.4.3 CT Scan
      • 1.4.4 Tissue Sampling
      • 1.4.5 PET-CT Scan
      • 1.4.6 Cerebral Arteriogram
      • 1.4.7 Lumbar Puncture
      • 1.4.8 Molecular Testing
      • 1.4.9 EEG
    • 1.5 Market by End User
      • 1.5.1 Global Brain Tumor Diagnosis And Therapeutics Market Size Growth Rate by End User
      • 1.5.2 Surgery
      • 1.5.3 Radiation Therapy
      • 1.5.4 Chemotherapy
      • 1.5.5 Immunotherapy
      • 1.5.6 Targeted Therapy
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Brain Tumor Diagnosis And Therapeutics Market Size
      • 2.1.1 Global Brain Tumor Diagnosis And Therapeutics Revenue 2014-2025
      • 2.1.2 Global Brain Tumor Diagnosis And Therapeutics Sales 2014-2025
    • 2.2 Brain Tumor Diagnosis And Therapeutics Growth Rate by Regions
      • 2.2.1 Global Brain Tumor Diagnosis And Therapeutics Sales by Regions
      • 2.2.2 Global Brain Tumor Diagnosis And Therapeutics Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Brain Tumor Diagnosis And Therapeutics Sales by Manufacturers
      • 3.1.1 Brain Tumor Diagnosis And Therapeutics Sales by Manufacturers
      • 3.1.2 Brain Tumor Diagnosis And Therapeutics Sales Market Share by Manufacturers
      • 3.1.3 Global Brain Tumor Diagnosis And Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Brain Tumor Diagnosis And Therapeutics Revenue by Manufacturers
      • 3.2.1 Brain Tumor Diagnosis And Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Brain Tumor Diagnosis And Therapeutics Revenue Share by Manufacturers (2014-2019)
    • 3.3 Brain Tumor Diagnosis And Therapeutics Price by Manufacturers
    • 3.4 Brain Tumor Diagnosis And Therapeutics Manufacturing Base Distribution, Product Types
      • 3.4.1 Brain Tumor Diagnosis And Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Brain Tumor Diagnosis And Therapeutics Product Type
      • 3.4.3 Date of International Manufacturers Enter into Brain Tumor Diagnosis And Therapeutics Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Brain Tumor Diagnosis And Therapeutics Sales by Product
    • 4.2 Global Brain Tumor Diagnosis And Therapeutics Revenue by Product
    • 4.3 Brain Tumor Diagnosis And Therapeutics Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Brain Tumor Diagnosis And Therapeutics Breakdown Data by End User

    6 North America

    • 6.1 North America Brain Tumor Diagnosis And Therapeutics by Countries
      • 6.1.1 North America Brain Tumor Diagnosis And Therapeutics Sales by Countries
      • 6.1.2 North America Brain Tumor Diagnosis And Therapeutics Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Brain Tumor Diagnosis And Therapeutics by Product
    • 6.3 North America Brain Tumor Diagnosis And Therapeutics by End User

    7 Europe

    • 7.1 Europe Brain Tumor Diagnosis And Therapeutics by Countries
      • 7.1.1 Europe Brain Tumor Diagnosis And Therapeutics Sales by Countries
      • 7.1.2 Europe Brain Tumor Diagnosis And Therapeutics Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Brain Tumor Diagnosis And Therapeutics by Product
    • 7.3 Europe Brain Tumor Diagnosis And Therapeutics by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Brain Tumor Diagnosis And Therapeutics by Countries
      • 8.1.1 Asia Pacific Brain Tumor Diagnosis And Therapeutics Sales by Countries
      • 8.1.2 Asia Pacific Brain Tumor Diagnosis And Therapeutics Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Brain Tumor Diagnosis And Therapeutics by Product
    • 8.3 Asia Pacific Brain Tumor Diagnosis And Therapeutics by End User

    9 Central & South America

    • 9.1 Central & South America Brain Tumor Diagnosis And Therapeutics by Countries
      • 9.1.1 Central & South America Brain Tumor Diagnosis And Therapeutics Sales by Countries
      • 9.1.2 Central & South America Brain Tumor Diagnosis And Therapeutics Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Brain Tumor Diagnosis And Therapeutics by Product
    • 9.3 Central & South America Brain Tumor Diagnosis And Therapeutics by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Brain Tumor Diagnosis And Therapeutics by Countries
      • 10.1.1 Middle East and Africa Brain Tumor Diagnosis And Therapeutics Sales by Countries
      • 10.1.2 Middle East and Africa Brain Tumor Diagnosis And Therapeutics Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Brain Tumor Diagnosis And Therapeutics by Product
    • 10.3 Middle East and Africa Brain Tumor Diagnosis And Therapeutics by End User

    11 Company Profiles

    • 11.1 GE Healthcare
      • 11.1.1 GE Healthcare Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GE Healthcare Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GE Healthcare Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.1.5 GE Healthcare Recent Development
    • 11.2 Hitachi
      • 11.2.1 Hitachi Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Hitachi Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Hitachi Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.2.5 Hitachi Recent Development
    • 11.3 Philips Healthcare
      • 11.3.1 Philips Healthcare Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Philips Healthcare Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Philips Healthcare Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.3.5 Philips Healthcare Recent Development
    • 11.4 Siemens Healthineers
      • 11.4.1 Siemens Healthineers Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Siemens Healthineers Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Siemens Healthineers Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.4.5 Siemens Healthineers Recent Development
    • 11.5 Toshiba Corporation
      • 11.5.1 Toshiba Corporation Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Toshiba Corporation Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Toshiba Corporation Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.5.5 Toshiba Corporation Recent Development
    • 11.6 Fujifilm Corporation
      • 11.6.1 Fujifilm Corporation Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Fujifilm Corporation Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Fujifilm Corporation Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.6.5 Fujifilm Corporation Recent Development
    • 11.7 Shimadzu Corporation
      • 11.7.1 Shimadzu Corporation Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Shimadzu Corporation Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Shimadzu Corporation Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.7.5 Shimadzu Corporation Recent Development
    • 11.8 Carestream Health
      • 11.8.1 Carestream Health Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Carestream Health Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Carestream Health Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.8.5 Carestream Health Recent Development
    • 11.9 Merck & Co.
      • 11.9.1 Merck & Co. Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Merck & Co. Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Merck & Co. Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.9.5 Merck & Co. Recent Development
    • 11.10 Astra Zeneca
      • 11.10.1 Astra Zeneca Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Astra Zeneca Brain Tumor Diagnosis And Therapeutics Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Astra Zeneca Brain Tumor Diagnosis And Therapeutics Products Offered
      • 11.10.5 Astra Zeneca Recent Development
    • 11.11 Bristol Myer Squibb
    • 11.12 Novartis
    • 11.13 Roche Diagnostics

    12 Future Forecast

    • 12.1 Brain Tumor Diagnosis And Therapeutics Market Forecast by Regions
      • 12.1.1 Global Brain Tumor Diagnosis And Therapeutics Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Brain Tumor Diagnosis And Therapeutics Revenue Forecast by Regions 2019-2025
    • 12.2 Brain Tumor Diagnosis And Therapeutics Market Forecast by Product
      • 12.2.1 Global Brain Tumor Diagnosis And Therapeutics Sales Forecast by Product 2019-2025
      • 12.2.2 Global Brain Tumor Diagnosis And Therapeutics Revenue Forecast by Product 2019-2025
    • 12.3 Brain Tumor Diagnosis And Therapeutics Market Forecast by End User
    • 12.4 North America Brain Tumor Diagnosis And Therapeutics Forecast
    • 12.5 Europe Brain Tumor Diagnosis And Therapeutics Forecast
    • 12.6 Asia Pacific Brain Tumor Diagnosis And Therapeutics Forecast
    • 12.7 Central & South America Brain Tumor Diagnosis And Therapeutics Forecast
    • 12.8 Middle East and Africa Brain Tumor Diagnosis And Therapeutics Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Brain Tumor Diagnosis And Therapeutics Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Diagnosis of a brain tumor is done by a neurologic exam (by a neurologist or neurosurgeon), CT (computer tomography scan) and/or magnetic resonance imaging (MRI), and other tests like an angiogram, spinal tap and biopsy. Diagnosis helps predict the treatment. This report mainly stuides Brain Tumor Diagnosis and Therapeutics market.
      CT scan segment held a lucrative revenue share in 2017 and is also likely to grow at a significant rate during the forecast period
      The global Brain Tumor Diagnosis And Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Brain Tumor Diagnosis And Therapeutics market based on company, product type, end user and key regions.

      This report studies the global market size of Brain Tumor Diagnosis And Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Brain Tumor Diagnosis And Therapeutics in these regions.
      This research report categorizes the global Brain Tumor Diagnosis And Therapeutics market by top players/brands, region, type and end user. This report also studies the global Brain Tumor Diagnosis And Therapeutics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GE Healthcare
      Hitachi
      Philips Healthcare
      Siemens Healthineers
      Toshiba Corporation
      Fujifilm Corporation
      Shimadzu Corporation
      Carestream Health
      Merck & Co.
      Astra Zeneca
      Bristol Myer Squibb
      Novartis
      Roche Diagnostics

      Market size by Product
      MRI
      CT Scan
      Tissue Sampling
      PET-CT Scan
      Cerebral Arteriogram
      Lumbar Puncture
      Molecular Testing
      EEG
      Market size by End User
      Surgery
      Radiation Therapy
      Chemotherapy
      Immunotherapy
      Targeted Therapy

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Brain Tumor Diagnosis And Therapeutics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Brain Tumor Diagnosis And Therapeutics market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Brain Tumor Diagnosis And Therapeutics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Brain Tumor Diagnosis And Therapeutics submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Brain Tumor Diagnosis And Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Brain Tumor Diagnosis And Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now